phase readout
saveNCT06722729: A Late Phase II Clinical Trial of KDT-3594 in Patients With Parkinson's Disease
ACTIVE_NOT_RECRUITINGupdated 17d ago
community read0 votes
Sponsor: Kissei Pharmaceutical Co., Ltd.. Phase: PHASE2. Conditions: Parkinson Disease
view source ↗
comments(0)
5-min edit window · permanent after that